Daniel Vittecoq

7.3k citations
147 papers · 3.8k · 1 hit paper · h-index 35

Impact in

  • Virology top 0.5%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

    • HIV/AIDS drug development and treatment 30
    • HIV/AIDS Research and Interventions 12
    • Pneumocystis jirovecii pneumonia detection and treatment 13
    • Hepatitis B Virus Studies 9

Daniel Vittecoq

138 papers receiving 3.6k citations

Daniel Vittecoq's Hit Papers

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial 2007 · 462 citations
4620+6+12Years since publication100200300400

Peers

Daniel Vittecoq
Comparison fields: 5 of 107
  • Virology 897
  • Infectious Diseases 1.7k
  • Emergency Medicine 740
  • Hepatology 590
  • Transplantation 163
Replace Esteban Ribera with:
Esteban Ribera Spain
Antonio Rivero Spain
Katia Boggian Switzerland
Elisa de Lazzari Spain
Christian Perronne France
Sophie Matheron France
Robin Isaacs United States
Shinichi Oka Japan
M. Dupon France
Hedy Teppler United States
Daniel Vittecoq relative to Esteban Ribera Spain Esteban Ribera's profile →
Citations per field
00.5×2×4×6.5×
Esteban Ribera · 1×
Citations per year

Countries citing papers authored by Daniel Vittecoq

Since Specialization
Citations

This map shows the geographic impact of Daniel Vittecoq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Vittecoq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Vittecoq more than expected).

Fields of papers citing papers by Daniel Vittecoq

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Vittecoq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Vittecoq. The network helps show where Daniel Vittecoq may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Vittecoq, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Vittecoq Line = papers co-authored together Daniel Vittecoq links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
Hit paper breakdown →
2007462
2 2005148
3 2007144
4 2004138
5 2009110
6 200396
7 200595
8 201491
9 199891
10 200774
11 200373
12 201770
13 199569
14 201863
15 201362
16 201459
17 200357
18 200957
19 199256
20 201055

About Daniel Vittecoq

Daniel Vittecoq is a scholar working on Infectious Diseases, Epidemiology, Hepatology, Emergency Medicine and Virology, having authored 147 papers that have together received 3.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (30 papers), Hepatitis C virus research (26 papers), HIV-related health complications and treatments (26 papers), HIV Research and Treatment (24 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers), HIV/AIDS Research and Interventions (12 papers), Hepatitis B Virus Studies (9 papers) and Antibiotic Resistance in Bacteria (8 papers). The work is most often cited by research in Virology (897 citations), Infectious Diseases (1.7k citations), Emergency Medicine (740 citations), Hepatology (590 citations) and Transplantation (163 citations). Daniel Vittecoq has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include L. Escaut, Elina Teicher, Christine Katlama, Jean-Jacques Monsuez, Didier Samuel, Robin Isaacs, Charles J. Gonzalez, Charlotte M. Harvey, Adriano Lazzarin and Beatriz Grinsztejn. Their work appears in journals such as Journal of Hepatology, JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS, Antimicrobial Agents and Chemotherapy and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact